Created from the founding vision that calcium compounds could do something genuinely useful inside the human body, Biocomposites has grown into one of the world’ s specialists in infection management in bone and soft tissue. Today, the company is part-way through its ambitious operational transformation, which includes a multimillion-pound facility expansion and a comprehensive automation program to ensure its operations can effectively scale alongside demand. To learn more about these investments and how they benefit the business, we speak with Stephen Liptrot, Global Operations Director, who has spent two years overseeing this strategy and fueling operational excellence.